NCT04865666

Brief Summary

The objective of this 8-week pilot pragmatic randomized controlled trial was to examine the real-world impact of movr on functional movement, flexibility, strength, and cardiovascular fitness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 25, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 14, 2020

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 29, 2021

Completed
Last Updated

April 29, 2021

Status Verified

April 1, 2021

Enrollment Period

5 months

First QC Date

April 26, 2021

Last Update Submit

April 26, 2021

Conditions

Keywords

mHealthfunctional movementflexibilitystrengthcardiovascular fitness

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in functional movement screen (FMS) at 8-week follow-up

    The 100-point version of the functional movement screen (FMS) was used to identify individual movement patterns. The FMS is a screening tool to assess full body movement patterns and consists of seven core movement tests (deep squat, hurdle step, in-line lunge, active straight-leg raise, shoulder flexibility, trunk stability push-up, and quadruped rotary stability). The seven FMS movement screens were performed by each participant and recorded using a portable observation lab (Noldus) with two video cameras (one shot on a sagittal plane \[side\] view and the other from a frontal plane \[front/back\] view). The standardized FMS verbal instructions were provided by the researcher. The video-based testing was completed to minimize participant burden during lab visits and to blind participants to their FMS scores for each of the movements. Scoring of the FMS was completed at a later time using the video recordings.

    Baseline and 8-week follow-up

Secondary Outcomes (10)

  • Change from baseline in flexibility at 8-week follow-up

    Baseline and 8-week follow-up

  • Change from baseline in muscular endurance at 8-week follow-up

    Baseline and 8-week follow-up

  • Change from baseline in handgrip strength at 8-week follow-up

    Baseline and 8-week follow-up

  • Change from baseline in lower body power at 8-week follow-up

    Baseline and 8-week follow-up

  • Change from baseline in cardiovascular fitness at 8-week follow-up

    Baseline and 8-week follow-up

  • +5 more secondary outcomes

Other Outcomes (5)

  • Changes from baseline in moderate-to-vigorous physical activity at 8-week follow-up

    Baseline and 8-week follow-up

  • Anthropometric measures completed at baseline and 8-week follow-up

    Baseline and 8-week follow-up

  • Changes from baseline in movr Movement Assessment scores at 4- and 8-week follow-up

    Baseline, and 4- and 8-week follow-up

  • +2 more other outcomes

Study Arms (2)

movr App Group

EXPERIMENTAL

Participants were instructed to maintain their usual physical activity, diet, and sleep behavior for the 8-week intervention period and to avoid any specialized exercise training for that time period, but they were also asked to use the movr app to supplement their current activity.

Device: movr mHealth App

Waitlist Control Group

NO INTERVENTION

Participants were instructed to maintain their usual physical activity, diet, and sleep behavior over the 8-week study period and to avoid any specialized exercise training for that time period. Following the 8-week study period, individuals in the control group were permitted to download and use the movr app if they chose to.

Interventions

The exercises prescribed through the movr app were accompanied with videos, images, and detailed instructions on how to complete them. These exercises consisted of basic movement and mobility patterns and are designed to promote functional movement. Participants were instructed to complete a total of four 'Minis' and two workout 'Builder' sessions per week. Workout Builders are designed to be longer exercise sessions tailored to the user's desired exercise time (15, 30, 45 or 60 min), equipment available (TRX Band, kettlebell, chin-up bar, dumbbells, foam roller, or none), target body region (lower, upper, or whole body), and specific exercise goal ('get sweaty,' 'build strength,' or 'develop mobility'). Version 3.6 of the movr app was used at the start of data collection and was updated to Version 4.1 over the course of the trial. No significant changes were made to the app or to the exercise prescription functionality throughout those updates.

movr App Group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Ages 18 to 50 years
  • Ability to read and write English
  • Owned a mobile device that could download applications from the App Store or Google Play

You may not qualify if:

  • Previously used the movr app
  • Had any contraindications to exercise based on the Get Active Questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diabetes Prevention Research Group Laboratory

Kelowna, British Columbia, V1V1V7, Canada

Location

Related Publications (1)

  • Stork MJ, Bell EG, Jung ME. Examining the Impact of a Mobile Health App on Functional Movement and Physical Fitness: Pilot Pragmatic Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021 May 28;9(5):e24076. doi: 10.2196/24076.

Study Officials

  • Mary E Jung, PhD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 26, 2021

First Posted

April 29, 2021

Study Start

September 25, 2019

Primary Completion

February 14, 2020

Study Completion

February 14, 2020

Last Updated

April 29, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations